Involvement of altered arginase activity, arginase I expression and NO production in accelerated intimal hyperplasia following cigarette smoke extract

Life Sciences

Volumn 83, Issue 13-14, 2008, Pages 453-459

  Nagai, Akiko ^a   Imamura, Masatoshi ^a   Watanabe, Takayasu ^a   Azuma, Hiroshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Arginase activity and protein expression; Cigarette smoke extract; Intimal hyperplasia; Nitric oxide

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE II; CIGARETTE SMOKE; CYCLIC GMP; NITRIC OXIDE; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ARGINASE; BLOTTING, WESTERN; CAROTID ARTERIES; CYCLIC GMP; ENDOTHELIAL CELLS; HYPERPLASIA; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS; SMOKE; TOBACCO; TUNICA INTIMA; UP-REGULATION;

ORYCTOLAGUS CUNICULUS;

EID: 52049124521     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.016     Document Type: Article

References (47)

1. Azuma H., Ishikawa M., and Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. British Journal of Pharmacology 88 2 (1986) 411-415
2. Azuma H., Niimi Y., and Hamasaki H. Prevention of intimal hyperplasia after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. British Journal of Pharmacology 106 (1992) 665-671
3. Azuma H., Hamasaki H., Niimi Y., Terada T., and Matsubara O. Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries. American Journal of Physiology. Heart and Circulatory Physiology 267 (1994) H2259-H2267
4. Blantz R.C., Satriano J., Gabbai F., and Kelly C. Biological effects of arginine metabolites. Acta Physiologica Scandinavica 168 1 (2000) 21-25
5. Boulanger C., and Luscher T.F. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. Acta Physiologica Scandinavica 85 2 (1990) 587-590
6. G-hydroxy-l-arginine, an intermediate in the l-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochemical and Biophysical Research Communications 203 (1994) 1614-1621
7. Chicoine L.G., Paffett M.L., Young T.L., and Nelin L.D. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 287 1 (2004) L60-L68
8. Chinkers M., and Garbers D.L. Signal transduction by guanylyl cyclases. Annual Reviews of Biochemical 60 (1991) 553-575
9. Cooke J.P. Role of nitric oxide in progression and regression of atherosclerosis. Western Journal of Medicine 164 5 (1996) 419-424
10. G-hydroxy-l-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochemical and Biophysical Research Communications 202 (1994) 174-180
11. Durante W., Johnson F.K., and Johnson R.A. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clinical and Experimental Pharmacology and Physiology 34 (2007) 906-911
12. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., and McKinley J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology 151 (1994) 54-61
13. Furchgott R.F. Role of endothelium in responses of vascular smooth muscle. Circulation Research 53 5 (1983) 557-573
14. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 83 5 (1989) 1774-1777
15. Green C.R., and Rodgman A. The Tobacco Chemists' Research Conference; a half-century of advances in analytical methodology of tobacco and its products. Recent Advances in Tobacco Science 22 (1996) 131-304
16. Hoshino S., Yoshida M., Inoue K., Yano Y., Yanagita M., Mawatari H., Yamane H., Kijima T., Kumagai T., Osaki T., Tachibana I., and Kawase I. Cigarette smoke extract induces endothelial cell injury via JNK pathway. Biochemical and Biophysical Research Communications 329 (2005) 58-63
17. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annual Review of Pharmacology and Toxicology 30 (1990) 535-560
18. Ignarro L.J., Buga G.M., Wei L.H., Bauer P.M., Wu G.Y., and del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 98 7 (2001) 4202-4208
19. Imamura M., Waseda Y., Marinova G.V., Ishibashi T., Obayashi S., Sasaki A., Nagai A., and Azuma H. Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 293 5 (2007) R2081-R2089
20. Ishizaka M., Nagai A., Iwanaga M., Imamura M., and Azuma H. Possible involvement of enhanced arginase activity due to up-regulated arginases and decreased hydroxyarginine in accelerating intimal hyperplasia with hyperglycemia. Vascular Pharmacology 47 (2007) 272-280
21. Jenkinson C.P., Grody W.W., and Cederbaum S.D. Comparative properties of arginases. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology 114 1 (1996) 107-132
22. Kepka-Lenhart D., Mistry S.K., Wu G.Y., and Morris Jr. S.M. Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages?. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279 6 (2000) R2237-R2242
23. Keidar S. Angiotensin, LDL peroxidation and atherosclerosis. Life Science 63 (1998) 1-11
24. Kim H., Liu X., Kobayashi T., Conner H., Kohyama T., Wen F.Q., Fang Q., Abe S., Bitterman P., and Rennard S.I. Reversible cigarette smoke extract-induced DNA damage in human lung fibroblast. American Journal of Physiology Respiratory Cell and Molecular Biology 31 (2004) R483-R490
25. Lefer A.M. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation 95 3 (1997) 553-554
26. Lefer A.M., and Ma X.L. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arteriosclerosis and Thrombosis 13 6 (1993) 771-776
27. Loyaga-Rendon R.Y., Sakamoto S., Beppu M., Aso T., Ishizaka M., Takahashi R., and Azuma H. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries. Atherosclerosis 178 2 (2005) 231-239
28. Masuda H., Goto M., Tamaoki S., and Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. British Journal of Pharmacology 126 (1999) 211-218
29. Masuda H., Tsujii T., Okuno T., Kihara K., Goto M., and Azuma H. Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired cavernosal relaxation with ischemia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 282 (2002) R1730-R1738
30. McDonald K.K., Zharikov S., Block E.R., and Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric oxide synthase may explain the arginine paradox. Journal of Biological Chemistry 272 (1997) 31213-31216
31. McVary K.T., Carrier S., and Wessells H. Subcommittee on smoking and erectile dysfunction socioeconomic committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence based analysis. Journal of Urology 166 5 (2001) 1624-1632
32. Miller R.A., and Wilson R.B. Atherosclerosis and myocardial ischemic lesions in alloxan-diabetic rabbits fed a low cholesterol diet. Atherosclerosis 4 (1984) 586-591
33. Moali C., Boucher J.L., Sari M.A., Stuehr D.J., and Mansuy D. Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N-omega-hydroxy derivatives, and N-omega-hydroxynor-l-arginine. Biochemistry 37 29 (1998) 10453-10460
34. Mori M., and Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochemical and Biophysical Research Communications 275 3 (2000) 715-719
35. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 5 2 (2001) 88-97
36. Niimi Y., Azuma H., and Hirakawa K. Repeated endothelial removal augments intimal thickening and attenuates EDRF release. American Journal of Physiology. Heart and Circulatory Physiology 226 (1994) H1348-H1356
37. Numao N., Masuda H., Sakai Y., Okada Y., Kihara K., and Azuma H. Roles of attenuated neuronal nitric-oxide synthase protein expression and accelerated arginase activity in impairing neurogenic relaxation of corpus cavernosum in aged rabbits. BJU international 99 6 (2007) 1495-1499
38. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., Mantelli B., Bronte V., and Zanovello P. Role of arginine metabolism in immunity and immunopathology. Immunobiology 212 (2007) 795-812
39. Ryoo S., Gupta G., Benjo A., Lim H.K., Camara A., Sikka G., Lim H.K., Sohi J., Santhanam L., Soucy K., Tuday E., Baraban E., Ilies M., Gerstenblith G., Nyhan D., Shoukas A., Christianson D.W., Alp N.J., Champion H.C., Huso D., and Berkowitz D.E. Endothelial arginase II - a novel target for the treatment of atherosclerosis. Circulation Research 102 (2008) 923-932
40. Sakai Y., Masuda H., Kihara K., Kurosaki E., Yamauchi Y., and Azuma H. Involvement of increased arginase activity in impaired cavernous relaxation with aging in the rabbit. Journal of Urology 172 1 (2004) 369-373
41. Sasaki A., Doi S., Mizutani S., and Azuma H. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. American Journal of Physiology. Lung Cellular and Molecular Physiology 292 6 (2007) L1480-L1487
42. Sydnor K.L., Allen C., and Higgins B. Effect of an aqueous extract of cigarette smoke condensate on benzo(a)pyrene-induced sarcoma and body weight in the rat. Journal of the National Cancer Institute 48 (1972) 893-909
43. Tabor C.W., and Tabor H. Polyamines. Annual Review of Biochemistry 53 (1984) 749-790
44. Wei L.H., Jacobs A.T., Morris Jr. S.M., and Ignarro L.J. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. American Journal of Physiology Cell Physiology 279 1 (2000) C248-C256
45. Yamaguchi Y., Matsuno S., Kagota S., Haginaka J., and Kunitomo M. Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress. European Journal of Pharmacology 436 (2002) 97-105
46. Yokode M., Kita T., Arai H., Kawai C., Narumiya S., and Fujiwara M. Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proceedings of the National Academy of Sciences 85 (1988) 2344-2348
47. Zhang C., Hein T.W., Wang W., Chang C.I., and Kuo L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB Journal 15 7 (2001) 1264-1266